1.Mechanism of Ki-67 in lung cancer and related progress in research on radiomics
Yuze WEI ; Zaiming LU ; Ying REN
Journal of China Medical University 2024;53(3):271-275
Radiomics is a new diagnostic and treatment technology,which can be employed to extract high-throughput radiomics features from CT,MR,and PET images and screen features closely related to diagnostic and treatment purposes,so as to accurately predict tumor or disease classification,prognosis,or genomic changes.Ki-67 is a type of nuclear protein,which is present only in nuclei of proliferative and dividing cells but not in those of quiescent phase cells;hence,it can be used as a predictor of cell proliferation and has been proven to be closely related to prognosis of lung cancer.This article reviews the mechanism and progress in radiomics research related to Ki-67 in lung cancer.
2.Application of kernel density estimation in predicting bone marrow dose of radiation therapy for gynecological tumors
Xiufeng CONG ; Jun CHEN ; Jingchao ZHANG ; Xiaoting ZHANG ; Zaiming LU
Chinese Journal of Radiation Oncology 2021;30(3):262-265
Objective:To predict the dose of lumbosacral spine (LS) and pelvic bone marrow (PBM) based on kernel density estimation (KDE) in patients with gynecological tumors.Methods:Fifteen patients with gynecological tumors receiving radiotherapy plans with dose limitation for LS and PBM in our hospital were selected as training data for machine learning. Another 10 cases were selected as the data for model validation. The minimum directional distance between the dose point in the organs and the edge of the planned target volume for the LS and PBM was calculated. Model training was performed by KDE. The accuracy of the model prediction was evaluated by the root mean square error. The model was utilized to predict the actual planned doses of the LS and PBM, and a linear fitting was performed on the predicted dose volume histogram (DVH) and actual results. The prediction effect was assessed by the goodness of fit R 2. Results:In terms of the DVH parameters required by the planner, the prediction doses from the model were similar to those of the verification plans: the difference of PBM V 40Gy was 2.0%, the difference of the mean dose was 1.6 Gy, and the difference of LS V 10Gy was -0.4%. In the unrequired DVH parameters, except for the PBM V 10Gy, the predicted values of the model were significantly high. The difference between the DVH predicted by the model and the actual plan was small, and the R 2 of the LS and PBM were 0.988 and 0.995, respectively. Conclusions:The model based on KDE method can accurately predict the doses of the LS and PBM. This model can also be used as a method to ensure the quality of the plan, and improve the consistency and quality of the plan.
3.Progress of signaling pathways regulating the sensitivity of irradiation in cancer therapy
Xiangxuan ZHAO ; Feng WEN ; Zaiming LU
Cancer Research and Clinic 2018;30(5):347-351
Radiotherapy characterized by invasive, localization and low toxicity has been recognized as one of the standard cancer therapy regimes, especially for non-surgically resectable advanced cancers. However, inherent and acquired resistance of cancer cells has significantly impeded the efficacy of radiotherapy. Of all the resistance determinants, varieties of anti-apoptotic signaling pathways or anti-survival proteins aberrant activation in malignant tumor cells play crucial roles in radiation insensitivity. This paper mainly focuses on clarifying the roles of the interesting key molecular signals including Ras, insulin-like growth factor type 1 receptor, transforming growth factor-beta, histone deacetylase and heat shock protein 90 in regulating radiotherapy sensitivity, in order to find the potential targets to improve the efficacy of radiotherapy.
4.Role of cell apoptosis regulated by P53 in treatment of hepatocellular carcinoma
Si GAO ; Xiangxuan ZHAO ; Zaiming LU
Journal of Clinical Hepatology 2017;33(7):1373-1376
P53 abnormality or mutation is commonly seen in patients with hepatocellular carcinoma (HCC), and therefore, restoration of P53 function has become a research hotspot in the treatment of HCC.This article reviews the association of P53 with Bcl-2 protein family, microRNA, TGFβ, HBV, HCV, and AKT and the role of P53 in regulating cell apoptosis, in order to provide clues for improving the therapeutic outcome of HCC.
5.Imaging performance of hepatic inflammatory myofibroblastic tumor
Xiaonan MAO ; Zaiming LU ; Qiyong GUO
Chinese Journal of Medical Imaging Technology 2017;33(4):554-557
Objective To assess the radiological imaging findings of hepatic inflammatory myofibroblastic tumor and to discuss the appropriate morphological classification.Methods A total of 22 patients with hepatic inflammatory myofibroblastic tumor confirmed by pathology were enrolled.Imaging performance of hepatic inflammatory myofibroblastic tumor were analyzed and the lesions were classified into appropriate type based on the imaging findings.Results Totally 23 lesions were found in 22 patients.The typical imaging features included great enhancement at later phase (13/20),moth eat en central necrosis (12/23) and peripheral shell (12/23).Seed in fruit was the most typical classification (8/23),followed by Seedless fruit (7/23).Conclusion Hepatic inflammatory myofibroblastic tumur typically shows as a single nodular lesion with moth eaten necrosis and peripheral shell like a Seed in fruit.The enhancement at later phase (especially the peripheral enhancement) can be regarded as a particular feature.
6.CT and MRI Findings and Follow-up Changes of Infantile Hepatic Hemangioendothelioma
Xiaoxia LIU ; Yaoyao ZHAI ; Zaiming LU
Chinese Journal of Medical Imaging 2017;25(9):671-674
Purpose To analyze the CT and MRI findings as well as follow-up changes of infantile hepatic hemangio-endothelioma (IHE),so as to provide basis for guiding the clinical establishment of therapeutic protocols.Materials and Methods The clinical data of 21 infants with IHE were analyzed retrospectively,including the imageological manifestations in initial diagnosis and during follow-up.Among the infants,3 received non-enhanced and enhanced scan of both CT and MRI,13 received non-enhanced and enhanced scan of CT only,while 5 received non-enhanced and enhanced scan of MRI only.All infants received ultrasonic examination.Results In non-enhanced CT scan,the tumor was marked by multiple or single intrahepatic low-density nidus with clear boundary,while non-enhanced MRI showed low T1WI signal and high T2WI signal.Enhanced scan of single IHE in arterial phase indicated notable nodular,streak-like and annular enhancement of the edge,while that in delayed period suggested a characteristic of progressive enhancement of tumor from periphery to center.There was not enhancement in necrotic zone in the center of large nidi all the time,while streak-like calcification nidi were found in partial nidi.Obvious whole-tumor enhancement was found in most nodes in the multiple nodular IHE,while moderate enhancement in partial nodes.The enhancement in each enhanced period decreased gradually,and most nidi in delayed period showed slightly high-density or isopycnic shadow.3 infants were misdiagnosed with hepatoblastoma and received surgical resection,but none had recurrence during postoperative ultrasonic follow-up.The rest infants were treated with oral administration of Propranolol and then followed up,and the follow-up results showed that most nidi shrunk to different extent while partial nidi disappeared completely.Conclusion IHE is marked by multiple nidi or single nidus,and the characteristic manifestations of CT and MRI are beneficial to promoting the accuracy rate of diagnosis of IHE.Tumor may shrink spontaneously or disappear if Propranolol is orally administered in treatment of IHE.
7.Current status and confusion in comprehensive interventional therapy for hepatocellular carcinoma
Journal of Clinical Hepatology 2016;32(1):44-48
In recent years,hepatocellular carcinoma (HCC)has become the second leading cause of cancer-related death worldwide.Due to the insidious onset of this disease,only 20%-30%of the patients with HCC have the opportunity for surgical resection or liver transplan-tation.At present,interventional therapy has become the first choice for patients with intermediate-stage HCC and some patients with late-stage HCC,and more and more scholars have realized the importance and necessity of comprehensive interventional therapy for HCC.The comprehensive interventional therapy of transcatheter arterial chemoembolization (TACE)in combination with various methods (TACE com-bined with local treatment,TACE sequential surgery,or TACE combined with systemic treatment)provides many therapeutic approaches and achieves good therapeutic effects.However,the indications,timing,and recurrence and metastasis after treatment for such combination ther-apies await further investigation.
8.The role of apoptosis in pancreatic cancer therapy
Xiangxuan ZHAO ; Feng WEN ; Zaiming LU
Practical Oncology Journal 2016;30(4):375-379
Pancreatic adenocarcinoma ( PAC) is still a refractory human digest malignancies due to multi-faceted causes ,late diagnosis and insensitive to traditional chemo -and radio-therapy .Resistance to apoptosis could be one of the most relevant mechanisms for PAC to escape any non -surgical therapy .This review aims to clear up the main deregulated apoptosis signal pathways over the years and to find out the abnormal molecule tar -get(s),and therefore,provide novel concepts for PAC molecular targeting therapy .
9.Study advances on the roles of apoptosis in hepatocellular carcinoma therapy
Xiangxuan ZHAO ; Feng WEN ; Xiaonan MAO ; Zaiming LU
Practical Oncology Journal 2016;30(5):448-452
Hepatocellular carcinoma ( HCC ) is one of the commonest malignant tumors in China .The therapeutic effects of conventional therapies including surgery resection at early stage ,chemotherapy or radiothera-py are greatly less than expected .One of the most possible reasons is the blockage of apoptosis in HCC cells .This review collects literatures about the studies on the roles of key signal pathways including RA ,STAT3,PDT,p53,β-catenin,TRAIL,microRNA and RAS in HCC therapy .This study may contribute greatly to providing outline in-sights for using apoptosis induction in liver cancer therapy .We hope it can promote the development liver cancer therapy in China .
10.The role of MAPK signaling pathway in development/progression and treatment of liver cancer
Wangjiu CIDAN ; Kun LIN ; Zaiming LU
Journal of Clinical Hepatology 2016;32(9):1810-1813
Abnormal activation of the mitogen-activated protein kinase (MAPK) signaling pathway is closely associated with the development, progression, and metastasis of liver cancer. This article introduces the expression of MAPK proteins in liver cancer and its role in the proliferation, differentiation, and metastasis of liver cancer, and elaborates on the value of the MAPK signaling pathway in the treatment and prognostic evaluation of liver cancer. It is pointed out that the MAPK signaling pathway plays an important role in the development/progression and treatment of liver cancer and is a potential molecular target for the treatment and prognostic evaluation of liver cancer.

Result Analysis
Print
Save
E-mail